# Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of <i>Kras</i> mutation-positive, non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-with-the-nitric-oxide-synthase-inhibitor-l-name-provides-a-survival/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicole L. Pershing,Chi‐Fu Jeffrey Yang,Mengmeng Xu,Christopher M. Counter |
| Citations | 26 |
| DOI | 10.18632/oncotarget.9874 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9874&path%5B%5D=31002 |
| OpenAlex ID | https://openalex.org/W2410260045 |
| PMID | 27285753 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Mengmeng Xu](https://scholariq.org/researchers/mengmeng-xu/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Paper topics

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.